[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349633-105":59,"doc-detail-349633-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","lncrna-dlgap1-as2-promotes-escc-progression-and-indicates-unfavorable-prognosis-via-the-mir-101-3pezh2-axis","LncRNA DLGAP1-AS2 promotes ESCC progression and indicates unfavorable prognosis via the miR-101-3p/EZH2 axis","","Objective: LncRNAs are crucial regulators and biomarkers in cancers, yet their expression and roles in esophageal squamous cell carcinoma (ESCC) remain insufficiently characterized. Methods: Using GEO, the study identified DLGAP1-AS2 among differentially expressed lncRNAs, validated by RT-qPCR in 135 paired tissues, and assessed prognosis with Kaplan-Meier and Cox analyses. Cell experiments (CCK-8, Transwell) and mechanistic assays (DLR, RIP) were performed. Results: DLGAP1-AS2 is upregulated, associates with advanced stage and lymph node metastasis, and predicts worse outcomes by activating EZH2 via miR-101-3p. Conclusion: DLGAP1-AS2 functions as an unfavorable prognostic biomarker and promotes malignant phenotypes while modulating ferroptosis in ESCC.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/lncrna-dlgap1-as2-promotes-escc-progression-and-indicates-unfavorable-prognosis-via-the-mir-101-3pezh2-axis/349633/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/lncrna-dlgap1-as2-promotes-escc-progression-and-indicates-unfavorable-prognosis-via-the-mir-101-3pezh2-axis/349633.png","ImageObject",300,407,{"name":92,"@type":93},"acoobca","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of the study on LncRNA DLGAP1-AS2 in ESCC?","Question",{"text":112,"@type":113},"To investigate the clinical relevance and underlying mechanisms of LncRNA DLGAP1-AS2 in esophageal squamous cell carcinoma, particularly through the miR-101-3p/EZH2 axis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was DLGAP1-AS2 expression and patient prognosis evaluated?",{"text":117,"@type":113},"DLDAP1-AS2 was identified using GEO and measured by RT-qPCR in 135 paired tumor and adjacent non-cancerous tissues. Prognostic effects were analyzed using Kaplan-Meier curves and Cox regression over a five-year follow-up.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanistic pathway links DLGAP1-AS2 to ESCC progression?",{"text":121,"@type":113},"DLGAP1-AS2 competitively binds miR-101-3p, leading to upregulation of EZH2, which promotes ESCC cell proliferation, migration, invasion, and EMT while influencing ferroptosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349633,1790907180,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985747870733,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Tang et al. Discover Oncology (2026) 17:1298 Discover Oncology  \n[https://doi.org/10.1007/s12672-026-05785-5](https://doi.org/10.1007/s12672-026-05785-5)  \nRESEARCH Open Access  \nLncRNA DLGAP1-AS2 promotes ESCC progression and indicates unfavorable prognosis via the miR-101-3p/EZH2 axis  \nLiwei Tang1, Yichuan Zhang2 and Xiangting Cheng3*  \n*Correspondence:  \nXiangting Cheng [chengxiangting881@163.com](chengxiangting881@163.com)[ ](chengxiangting881@163.com)1Department of Thoracic Surgery, The First Affiliated Hospital of Ningbo University, Ningbo 315000, China  \n2Minimally Invasive Endoscopy Center, Digestive Disease Center, The Affiliated Hospital of Panzhihua University, Panzhihua 617000, China 3Department of Gastrointestinal Surgery, Zibo Central Hospital, No. 54, Communist Youth League West Road, Zhangdian District, Zibo 250036, China  \nAbstract  \nObjective LncRNAs are crucial regulators and biomarkers in various cancers. However, their expression and functions in esophageal squamous cell carcinoma (ESCC) remain largely unexplored. This study explored the clinial relevance and mechanisms of LncRNA DLGAP1-AS2 in ESCC.  \nMethods Utilizing the GEO dataset, the identification of differentially expressed lncRNAs in ESCC encompassed DLGAP1-AS2 . RT-qPCR was employed to measure its expression in 135 paired tumors and adjacent non-cancerous tissue samples. Patients were followed up for five years. Kaplan-Meier curves and Cox regression analysis evaluated DLGAP1-AS2’s prognostic impact, while CCK-8 and Transwell assays assessed cell proliferation. Additionally, commercial assay kits measured ROS, MDA, GSH, andiron levels. DLR and RIP assays confirmed miR-101-3p targeting DLGAP1-AS2 and EZH2 . Results DLGAP1-AS2 was markedly upregulated in ESCC tumor tissues and cell lines. High expression of DLGAP1-AS2 correlated with advanced clinical stages and extensivelymph node metastasis in ESCC patients, and patients with elevated DLGAP1-AS2 expression had a worse prognosis. Mechanistically, DLGAP1-AS2 competitively binds miR-101-3p, upregulating EZH2 . Depleting DLGAP1-AS2 significantly curbed ESCC cell proliferation, migration, invasion, and EMT, while boosting ferroptosis—an effect notably reversed by miR-101-3p reduction.  \nConclusion DLGAP1-AS2 acts as a potential biomarker for unfavorable prognosis in ESCC patients. Mechanistically, it promotes malignant phenotypes of ESCC cells in vitro by regulating the miR-101-3p/EZH2 axis, enhancing proliferation and EMT, while suppressing ferroptosis.  \nKeywords DLGAP1-AS2, ESCC, miR-101-3p, Prognostic, Biomarker  \n1 Introduction  \nEsophageal cancer (ESCA) is a common digestive malignancy, sixth in global cancer deaths [1]. Over 440,000 die from it annually [2]. Esophageal squamous cell carcinoma (ESCC) is the main pathological type in Asian and African countries, especially China, where it accounts for over 90% of cases [1]. Earlier diagnosis is critical for ESCC patients,  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativec","cbCaih67VFCS44t5","https://ap.wps.com/l/cbCaih67VFCS44t5","pdf",4234292,18,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Background on ESCA and ESCC\n## Roles of lncRNAs and miRNAs","[{\"question\":\"What is the main objective of the study on LncRNA DLGAP1-AS2 in ESCC?\",\"answer\":\"To investigate the clinical relevance and underlying mechanisms of LncRNA DLGAP1-AS2 in esophageal squamous cell carcinoma, particularly through the miR-101-3p/EZH2 axis.\"},{\"question\":\"How was DLGAP1-AS2 expression and patient prognosis evaluated?\",\"answer\":\"DLDAP1-AS2 was identified using GEO and measured by RT-qPCR in 135 paired tumor and adjacent non-cancerous tissues. Prognostic effects were analyzed using Kaplan-Meier curves and Cox regression over a five-year follow-up.\"},{\"question\":\"What mechanistic pathway links DLGAP1-AS2 to ESCC progression?\",\"answer\":\"DLGAP1-AS2 competitively binds miR-101-3p, leading to upregulation of EZH2, which promotes ESCC cell proliferation, migration, invasion, and EMT while influencing ferroptosis.\"}]","LncRNA DLGAP1-AS2 promotes ESCC progression and indicates unfavorable prognosis via the miR-101-3p/EZH2 axis | PDF",1790084602,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c7404c4ea75355a63da58d703edfed5.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d96b092ffadd5fa8e3cd922150d60554.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6273d4688a6a2360ee4f147ae6ec14b0.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9202c5b4e6437053a1ea53236ed441d5.webp",980,1306]